Home 
Site Map
Site Map
Site Map
Main Menu
- Home
- The Company
- Partners & Staff
- Sotiris N Nikolopoulos PhD, MS | Molecular Oncologist (Scientific Director)
- Stella Georgiou PhD, MS (Scientist)
- Evangelia Kalimani, MS (Scientist)
- Fotis Kirilis, MS
- Savvoula Malliou, MD, PhD | Pathologist-Oncologist (personalized therapy collaborator)
- Christos Karalis, MD | Pathologist, Endoscopist (FNAs and biopsies collaborator)
- Dimitris Moraitis | Head and Neck surgeon (Thyroid project collaborator)
- Georgios Tsoumalis, MD, PhD | Endocrinologist (Thyroid project collaborator)
- Thomas Theodosiadis-Thomaidis, PhD | Chemical Engineer
- George Sgouridis | Electronics Engineer (Systems Engineer)
- Efi Nteli | Accountant (Administrator)
- Strategic Partnerships
- Career Opportunities
- Company News
- Partners & Staff
- Services
- Hereditary Dieseases Detection
- Prognosis - Diagnosis
- RESPONSE TO EGFR-TARGETED THERAPIES
- TRADITIONAL VS MOLECULAR TUMOR ANALYSIS
- Detection and quantitative assessment of activating mutations in genes that control the effectiveness of targeted therapies
- Gene expression (quantitative assessment) of genes that regulate the response of cancer cells to chemotherapy drugs
- Gene expression (quantitative assessment) of mitotic genes
- Gene expression (quantitative assessment) of antiapoptotic genes
- Gene expression (quantitative assessment) of tumor suppressor genes
- Gene expression (quantitative assessment) of transcription factors
- Gene expression (quantitative assessment) of growth factors
- Gene expression (quantitative assessment) of hormonal receptors
- Gene expression (quantitative assessment) of cell surface receptors
- RELATIVE QUANTITATIVE GENE EXPRESSION FOR DETECTION OF FREE CIRCULATING CANCER CELLS AND DISEASE MONITORING
- RELATIVE QUANTITATIVE GENE EXPRESSION FOR PREDICTION OF TUMOR RESPONSE TO CHEMOTHERAPY
- Tumor or biopsy molecular profile for prognosis-diagnosis and targeted therapy
- Cell surface receptors
- Research
- Knowledge Base
- Refereed Journals Publications
- Netrin-integrin Signaling in Epithelial Morphogenesis, Axon Guidance Perspective and Vascular Patterning
- Targeted Deletion of the Integrin β4 Signaling Domain Suppresses Laminin-5-Dependent Nuclear Entry of Mitogen-Activated Protein Kinases and NF-κB, Causing Defects in Epidermal Growth and Migration
- Integrin β4 signaling promotes tumor angiogenesis
- Molecular Dissection of Actopaxin-Integrin-linked Kinase-Paxillin Interactions and Their Role in Subcellular Localization
- Integrin-linked Kinase (ILK) Binding to Paxillin LD1 Motif Regulates ILK Localization to Focal Adhesions
- The human non-muscle a-actinin protein encoded by the ACTN4 gene suppresses tumorigenicity of human neuroblastoma cells
- Actopaxin, a New Focal Adhesion Protein That Binds Paxillin LD Motifs and Actin and Regulates Cell Adhesion
- Miscellaneous
- Cancer Types
- Gene Expression
- Refereed Journals Publications
- Contact Us
- Login
Image of the day
